Literature DB >> 2815179

Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program.

K Yano1, D M Reed, C J MacLean.   

Abstract

During an average 18 years of follow-up for 7,850 Japanese-American men in Hawaii who were free of stroke at entry, 116 developed hemorrhagic stroke (subarachnoid hemorrhage or intracerebral hemorrhage). There was a significant (p = 0.001) inverse association between serum cholesterol and the risk of intracerebral hemorrhage but not of subarachnoid hemorrhage. This inverse association was nonlinear, with a higher incidence rate only for men with serum cholesterol in the lowest quintile (less than 189 mg/dl). The relative risk (lowest quintile/other four quintiles) was 2.55 (95% confidence interval 1.58-4.12) after controlling for age, blood pressure, serum uric acid, cigarette smoking, and alcohol consumption. There was no evidence for an interaction between blood pressure and serum cholesterol, although the inverse association was stronger for normotensive than for hypertensive men. Public health implications would differ in different countries depending on the relative frequency of intracerebral hemorrhage and on the distribution of serum cholesterol levels in the population.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2815179     DOI: 10.1161/01.str.20.11.1460

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  55 in total

1.  Cholesterol and strokes. Cholesterol lowering is indicated for strokes due to carotid atheroma.

Authors:  M F Oliver
Journal:  BMJ       Date:  2000-02-19

2.  The inverse relation of average population blood pressure and stroke mortality rates in the seven countries study: a paradox.

Authors:  A Menotti; H Blackburn; D Kromhout; A Nissinen; M Karvonen; C Aravanis; A Dontas; F Fidanza; S Giampaoli
Journal:  Eur J Epidemiol       Date:  1997-06       Impact factor: 8.082

3.  Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.

Authors:  S Warshafsky; D Packard; S J Marks; N Sachdeva; D M Terashita; G Kaufman; K Sang; A J Deluca; S J Peterson; W H Frishman
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

4.  Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study.

Authors:  Shah Ebrahim; Joohon Sung; Yun-Mi Song; Robert L Ferrer; Debbie A Lawlor; George Davey Smith
Journal:  BMJ       Date:  2006-06-06

5.  SPARCL: statin therapy for stroke patients is not crystal clear.

Authors:  Robert S Rosenson
Journal:  Curr Atheroscler Rep       Date:  2007-09       Impact factor: 5.113

6.  Apolipoprotein E, statins, and risk of intracerebral hemorrhage.

Authors:  Daniel Woo; Ranjan Deka; Guido J Falcone; Matthew L Flaherty; Mary Haverbusch; Sharyl R Martini; Steven M Greenberg; Alison M Ayres; Laura Sauerbeck; Brett M Kissela; Dawn O Kleindorfer; Charles J Moomaw; Christopher D Anderson; Joseph P Broderick; Jonathan Rosand; Carl D Langefeld; Jessica G Woo
Journal:  Stroke       Date:  2013-09-05       Impact factor: 7.914

7.  Subacute decline in serum lipids precedes the occurrence of primary intracerebral hemorrhage.

Authors:  Chia-Ling Phuah; Miriam R Raffeld; Alison M Ayres; Anand Viswanathan; Steven M Greenberg; Alessandro Biffi; Jonathan Rosand; Christopher D Anderson
Journal:  Neurology       Date:  2016-04-29       Impact factor: 9.910

Review 8.  Treating hypercholesterolemia: looking forward.

Authors:  Antonio M Gotto
Journal:  Clin Cardiol       Date:  2003-01       Impact factor: 2.882

9.  Atorvastatin in stroke: a review of SPARCL and subgroup analysis.

Authors:  Branko N Huisa; Andrew B Stemer; Justin A Zivin
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

Review 10.  Clinical review: Critical care management of spontaneous intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Crit Care       Date:  2008-12-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.